GO:0035364 thymine transport: Nucleobase Salvage Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035364 (thymine transport) describes the directed movement of thymine (5-methyluracil) into, out of, or within a cell by transporters or pores.
• Thymine is a pyrimidine nucleobase that must cross membranes to enter salvage pathways for DNA synthesis and repair.
• Transport of thymine and other nucleobases is mediated by specific membrane proteins, including members of the solute carrier (SLC) family.
• Nucleobase transport is relevant to drug delivery and resistance, as seen with trypanocide and anticancer therapies.
• Experimental study of thymine transport uses gene knockout, point mutation, knock-in, and overexpression cell models combined with uptake assays and omics.
• Dysregulation of nucleobase transport can influence cancer cell proliferation and chemotherapy response.
Description
Thymine transport (GO:0035364) is the biological process by which the pyrimidine nucleobase thymine (5-methyluracil) is moved across cellular membranes or between cellular compartments by means of a transporter or pore. This process is essential for nucleobase salvage, allowing cells to take up exogenous thymine and convert it into thymidine nucleotides for DNA synthesis and repair. Because thymine is a key building block of DNA, its transport directly impacts genome maintenance and cell proliferation. Researchers study thymine transport to understand how cells acquire nucleobases, how transport defects contribute to disease, and how to deliver nucleobase analog drugs more effectively. The process is also relevant to chemical radiosensitization, where modified nucleobases and their transport influence cellular responses to radiation. In this article, we integrate the QuickGO definition of GO:0035364 with published literature to provide a research-grade overview of thymine transport, its molecular players, and the experimental models used to investigate it.
thymine transport At A Glance
| GO ID | GO:0035364 |
|---|---|
| GO term | thymine transport |
| Ontology | biological_process |
| Synonym | 5-methyluracil transport; thymine transmembrane transport |
| Definition | The directed movement of thymine, 5-methyluracil, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
| Major function | Uptake and distribution of thymine for nucleobase salvage and DNA synthesis |
| Related molecules | Nucleobase transporters (e.g., SLC family members), thymine, 5-methyluracil |
| Cellular context | Plasma membrane and organellar membranes |
| Research relevance | Drug delivery, chemotherapy resistance, radiosensitization, and metabolic disorders |
What Is GO:0035364?
According to the Gene Ontology, GO:0035364 (thymine transport) is defined as the directed movement of thymine, 5-methyluracil, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. In simpler terms, it is the process that controls how thymine crosses biological membranes, either into a cell, out of a cell, or between different cellular compartments, using dedicated transport proteins.
Why Is thymine transport Important in Cell Biology?
Thymine transport is important because it governs the availability of thymine for nucleotide salvage pathways, which are critical for DNA replication and repair in many cell types. Defects or alterations in nucleobase transport can affect cell proliferation, drug sensitivity, and resistance to therapies such as trifluridine/tipiracil in colorectal cancer. In addition, nucleobase transporters are targets for antiparasitic drugs, as seen in African trypanosomiasis, where drug uptake and resistance depend on transport mechanisms. Understanding thymine transport therefore has broad implications for cancer biology, infectious disease, and pharmacology.
• Provides thymine for salvage pathways of DNA synthesis and repair.
• Influences cellular sensitivity to nucleobase analog drugs used in cancer therapy.
• Contributes to drug uptake and resistance in parasitic infections such as African trypanosomiasis.
• Plays a role in chemical radiosensitization by modulating nucleobase availability.
• Affects metabolic homeostasis of pyrimidines in normal and diseased cells.
• Is a potential target for improving drug delivery across biological membranes.
• Helps explain inter-individual differences in drug response.
• Links membrane transport to genome stability and cell cycle progression.
• Relevant to understanding bioelectrogenesis and membrane transport phenomena.
• Supports development of transport-targeted therapeutics.
What Happens During thymine transport?
Recognition and binding of thymine by transporters
In simple terms: Transport proteins on the cell membrane recognize and grab thymine molecules.
Thymine transport begins when a membrane transporter recognizes thymine (5-methyluracil) with sufficient affinity to bind it. These transporters are typically integral membrane proteins that form a translocation pathway for nucleobases. The binding step is selective, allowing the cell to distinguish thymine from other nucleobases and metabolites. In some systems, transport is coupled to ion gradients or other energy sources, while in others it is facilitated diffusion.
Translocation across the lipid bilayer
In simple terms: The transporter moves thymine through the membrane from one side to the other.
After binding, the transporter undergoes conformational changes that move thymine across the lipid bilayer. This translocation step is the core of the transport process and can be directed into the cell (uptake), out of the cell (efflux), or between compartments. The direction and rate depend on the type of transporter and cellular conditions. For example, some transporters mediate uptake of nucleobases for salvage, while others may export them.
Release of thymine into the target compartment
In simple terms: Once across, the transporter releases thymine so it can be used by the cell.
Upon reaching the other side of the membrane, the transporter releases thymine into the cytoplasm or organelle lumen. The released thymine can then enter salvage pathways, where it is converted to thymidine nucleotides for DNA synthesis. This release step is essential for making thymine available for downstream metabolic reactions.
Coupling to cellular metabolism and salvage pathways
In simple terms: Thymine is then used to build DNA or is further processed.
After transport, thymine is phosphorylated and incorporated into nucleotides via salvage enzymes. This links transport directly to DNA replication and repair. In cancer cells, increased thymine transport can support rapid proliferation and influence response to antimetabolite drugs. In parasites, nucleobase transport is critical for drug uptake and resistance.
Regulation and adaptation of transport activity
In simple terms: Cells can adjust how much thymine they take up based on their needs.
Thymine transport activity can be regulated at the level of transporter expression, localization, or activity. Cells may upregulate transporters under conditions of high demand for nucleotides, such as during proliferation or stress. Conversely, downregulation can limit drug uptake and contribute to resistance. This regulation ensures that thymine availability matches cellular requirements.
Key Genes Involved in GO:0035364 thymine transport
The following genes and proteins have been implicated in thymine transport or related nucleobase transport processes based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC29A1 | Equilibrative nucleoside transporter; may transport nucleobases including thymine | Studied in drug uptake and resistance |
| SLC29A2 | Equilibrative nucleoside transporter family member | Potential role in nucleobase transport |
| SLC22A1 | Organic cation transporter; transports small molecules | May influence nucleobase analog uptake |
| SLC22A2 | Organic cation transporter | Candidate for nucleobase transport |
| SLC22A3 | Organic cation transporter | Expressed in various tissues; transport of nucleobases |
| SLC7A11 | Cystine/glutamate transporter; linked to ferroptosis | Indirectly affects nucleobase metabolism and drug response |
| TP53 | Tumor suppressor; regulates metabolism and transport | Mutations alter transport and drug sensitivity |
| TYMS | Thymidylate synthase; thymine nucleotide synthesis | Target of anticancer drugs; linked to transport |
| DPYD | Dihydropyrimidine dehydrogenase; pyrimidine catabolism | Affects thymine availability |
| UCK2 | Uridine-cytidine kinase; pyrimidine salvage | Downstream of thymine transport |
| TK1 | Thymidine kinase 1; salvage of thymidine | Links transport to DNA synthesis |
| SLC5A8 | Sodium-coupled monocarboxylate transporter | May transport nucleobases |
| SLC16A1 | Monocarboxylate transporter | Potential nucleobase transport |
| ABCB1 | ATP-binding cassette transporter; efflux pump | May export nucleobase analogs |
| ABCG2 | ABC transporter; efflux of drugs | Influences drug resistance |
| OATP5A1 | Organic anion transporting polypeptide; transports vitamins and amino acids | Deorphanized as transport protein; may relate to nucleobase transport |
| SLC25A | Mitochondrial carriers | Potential transport of nucleobases across mitochondrial membranes |
How Is thymine transport Regulated?
Thymine transport is regulated at multiple levels. Transporter gene expression can be induced by cellular demand for nucleotides, such as during proliferation or after DNA damage. Post-translational modifications and membrane trafficking can alter the amount of transporter at the cell surface. In cancer, oncogenic signaling pathways may upregulate nucleobase transporters to support growth, while tumor suppressor p53 can modulate transport and metabolism. Additionally, drug exposure can select for cells with altered transport activity, leading to resistance.
thymine transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC7A11 | Colorectal cancer, ferroptosis | 3D organoids with p53 mutation |
| TP53 | Cancer drug response | Knockout and point mutation cell lines |
| SLC29A1 | Drug resistance | Overexpression and knockout models |
| OATP5A1 | Transport of vitamins and amino acids | Knockout and knock-in cell lines |
| ABCB1 | Multidrug resistance | Overexpression and CRISPR knockout |
Cancer and chemotherapy response
Altered thymine transport can affect the uptake of nucleobase analog drugs such as trifluridine/tipiracil, influencing ferroptosis and therapeutic outcomes in colorectal cancer. Transporters like SLC7A11 and p53 status modulate drug sensitivity, making thymine transport a potential biomarker and target.
Parasitic infections
In African trypanosomiasis, nucleobase transporters are critical for drug uptake, and changes in transport can lead to resistance against trypanocides. Understanding thymine transport in parasites may inform new therapeutic strategies.
Radiosensitization and DNA damage
Chemical radiosensitization involves modified nucleobases, and their transport into cells can influence the response to radiation therapy. Thymine analogs used as radiosensitizers require efficient transport to reach their targets.
Metabolic and neurological disorders
Nucleobase transport defects may contribute to metabolic imbalances, and genetic studies have linked transport and intelligence-related genes, though direct evidence for thymine transport in neurodevelopment is limited.
From thymine transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate transporter reduce thymine uptake? | CRISPR knockout cell line |
| Does a specific point mutation alter transport activity? | Point mutation knock-in cell line |
| Can tagging a transporter reveal its localization? | Tagged knock-in (e.g., GFP) |
| Does overexpression increase drug sensitivity? | Overexpression cell line |
| Which genes regulate thymine transport? | CRISPR library screening |
| How does transport affect global metabolism? | Metabolomics and transcriptomics |
How to Study the thymine transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled thymine uptake | Transport rate | Quantify uptake in wild-type vs mutant cells |
| Fluorescent thymine analogs | Transport and localization | Live-cell imaging |
| CRISPR knockout screening | Genes affecting transport | Identify novel regulators |
| RNA-seq | Transporter gene expression | Compare conditions |
| Proteomics | Protein abundance and modifications | Validate expression changes |
| Metabolomics | Intracellular thymine and nucleotides | Assess metabolic impact |
| Cell viability assays | Drug sensitivity | Link transport to resistance |
| Organoid models | 3D tissue-like response | Cancer drug testing |
Uptake assays with radiolabeled or fluorescent thymine
Direct measurement of thymine transport can be performed using radiolabeled thymine or fluorescent analogs in cultured cells. These assays quantify the rate of uptake and can be combined with transporter inhibitors to identify specific pathways.
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify genes that regulate thymine transport and drug sensitivity. Such screens have been used to uncover pathways affecting ferroptosis and chemotherapy response.
Transcriptomics and proteomics
RNA-seq and proteomics can reveal changes in transporter expression under different conditions. These approaches help link transport activity to cellular states such as proliferation or stress.
Imaging and subcellular localization
Fluorescent tagging of transporters allows visualization of their localization and trafficking in live cells. This can reveal whether transport occurs at the plasma membrane or in organelles.
How CRISPR Can Be Used to Study GO:0035364 thymine transport
Knockout
CRISPR knockout of candidate transporter genes can abolish thymine transport, allowing researchers to test causality. Knockout cell lines are essential for validating whether a specific gene is required for uptake.
Point Mutation
Introducing point mutations in transporter genes can mimic human polymorphisms or catalytic residues, revealing structure-function relationships. These models help determine which residues are critical for thymine recognition and translocation.
Knock-in
Knock-in of tagged or reporter versions of transporters enables tracking of protein localization and dynamics. This approach can also be used to express human variants in model organisms.
Overexpression
Overexpression of transporters can increase thymine uptake and sensitize cells to nucleobase analog drugs. Such models are useful for studying drug transport and resistance mechanisms.
How EDITGENE Supports thymine transport Research
Researchers studying thymine transport-related genes often need to determine whether a candidate gene is causally involved in uptake, metabolism, or drug response. EDITGENE provides custom CRISPR cell models to interrogate these questions with precision.
Contact EDITGENE today to design your custom CRISPR model for thymine transport research.
Frequently Asked Questions About thymine transport
What is thymine transport?
Thymine transport (GO:0035364) is the directed movement of thymine, 5-methyluracil, across cellular membranes by transporters or pores.
What genes are involved in thymine transport?
Genes encoding nucleobase transporters such as SLC29A1, SLC22A1, and SLC7A11 have been implicated in thymine and nucleobase transport.
Why is thymine transport important for cancer?
It affects the uptake of anticancer drugs like trifluridine/tipiracil and influences ferroptosis and drug resistance.
How is thymine transport studied?
Common methods include radiolabeled uptake assays, CRISPR knockout screens, and omics analyses.
What is the GO definition of thymine transport?
The GO definition is the directed movement of thymine, 5-methyluracil, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
Which diseases are linked to thymine transport?
Cancer, parasitic infections, and metabolic disorders have been linked to altered nucleobase transport.
Can thymine transport be targeted therapeutically?
Yes, modulating transport can enhance drug delivery or overcome resistance in cancer and infections.
What are the synonyms for thymine transport?
Synonyms include 5-methyluracil transport and thymine transmembrane transport.
How does thymine transport relate to DNA synthesis?
Transported thymine enters salvage pathways to produce thymidine nucleotides for DNA replication and repair.
What model systems are used for thymine transport research?
CRISPR knockout, point mutation, knock-in, overexpression cell lines, and organoids are commonly used.
Conclusion
Thymine transport (GO:0035364) is a fundamental biological process that controls the movement of thymine across membranes, impacting DNA synthesis, drug response, and disease. Understanding its molecular players and regulation provides opportunities for therapeutic intervention in cancer and infectious diseases. Continued research using advanced CRISPR models and omics approaches will further elucidate its roles in health and disease.
References
- 1. Junkiert-Czarnecka A et al.. 2016. Genetical background of intelligence.. Postepy Hig Med Dosw (Online) 70(0):590-8 PMID: 27333929
- 2. Del Prado A et al.. 2020. Functional Systems Derived from Nucleobase Self-assembly.. ChemistryOpen 9(4):409-430 PMID: 32257750
- 3. Cadet J et al.. 1977. Molecular aspects of chemical radiosensitization.. J Radiat Res 18(2):93-101 PMID: 142147
- 4. Schoffeniels E. 1989. [Molecular aspects of bioelectrogenesis].. Arch Int Physiol Biochim 97(5):389-402 PMID: 2480095
- 5. Kohlmann E et al.. 2026. Deorphanisation and functional characterisation of OATP5A1 as transport protein for amino acids and vitamins.. Cell Mol Biol Lett 31(1) PMID: 42231149
- 6. Huang M et al.. 2025. Trifluridine/tipiracil induces ferroptosis by targeting p53 via the p53-SLC7A11 axis in colorectal cancer 3D organoids.. Cell Death Dis 16(1):255 PMID: 40188162
- 8. Kasozi KI et al.. 2022. An Update on African Trypanocide Pharmaceutics and Resistance.. Front Vet Sci 9:828111 PMID: 35356785
